Does OMALIZUMAB Cause Sluggishness? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Sluggishness have been filed in association with OMALIZUMAB (Omalizumab-igec). This represents 0.1% of all adverse event reports for OMALIZUMAB.
38
Reports of Sluggishness with OMALIZUMAB
0.1%
of all OMALIZUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Sluggishness From OMALIZUMAB?
Of the 38 reports, 6 (15.8%) required hospitalization, and 1 (2.6%) were considered life-threatening.
Is Sluggishness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OMALIZUMAB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does OMALIZUMAB Cause?
No adverse event (9,736)
Asthma (9,354)
Urticaria (9,231)
Off label use (9,199)
Dyspnoea (8,323)
Drug ineffective (6,747)
Cough (5,926)
Pruritus (5,224)
Fatigue (5,053)
Malaise (4,820)
What Other Drugs Cause Sluggishness?
SACUBITRIL\VALSARTAN (212)
ADALIMUMAB (202)
RISPERIDONE (196)
LEVOTHYROXINE (160)
TREPROSTINIL (141)
SODIUM OXYBATE (134)
LENALIDOMIDE (131)
ETANERCEPT (126)
CARBIDOPA\LEVODOPA (117)
CLONAZEPAM (106)
Which OMALIZUMAB Alternatives Have Lower Sluggishness Risk?
OMALIZUMAB vs OMAVELOXOLONE
OMALIZUMAB vs OMBITASVIR
OMALIZUMAB vs OMBITASVIR\PARITAPREVIR\RITONAVIR
OMALIZUMAB vs OMEGA-3-ACID ETHYL ESTERS
OMALIZUMAB vs OMEGA-3-CARBOXYLIC ACIDS